Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-12

AUTHORS

S. Bonvalot, H. Eldweny, C. Le Péchoux, D. Vanel, P. Terrier, A. Cavalcanti, C. Robert, N. Lassau, A. Le Cesne

ABSTRACT

BACKGROUND: The role for surgery in patients with "unresectable" gastrointestinal stromal tumors (GIST) treated with imatinib is still not defined. The objective of this retrospective study was to evaluate the feasibility and benefit of this secondary surgery. METHODS: Progression-free survival (PFS) in a group of patients who underwent secondary surgery was compared to that of patients treated exclusively with imatinib. RESULTS: Of 180 patients with unresectable GIST treated with Imatinib, 22 (12%) underwent secondary surgery, following which one patient achieved a complete radiological response, 19 achieved a partial response (PR), in one patient the disease was stable, and in one patient there was reactivation of local occlusive disease after an initial PR. No patient with overall progression was to undergo surgery. At the beginning of imatinib therapy, five patients with metastases underwent emergency surgery [hemorrhage (n = 3) due to rupture of large necrotic masses], which ultimately resulted in three of the five patients dying postoperatively. A macroscopically complete resection was achieved in all primary tumors (5/5) and in ten of the 17 metastases. Pathological analysis revealed two complete response (CR) and 17 PR, and no treatment effect was evidenced in three patients. Two-year overall survival after surgery was 62%. The median PFS calculated from the initiation of imatinib therapy was 18.7 months for all operated patients and 23.4 months after planned surgery. CONCLUSION: Primary tumors that become amenable to surgery with prior imatinib therapy, evolving necrosis and localized progression (to avoid life-threatening complications) could benefit from this secondary surgery. For the majority of other residual lesions, the potential benefit of secondary surgery should be evaluated in randomized studies in the future since PFS is similar to that reported among non-operated patients. More... »

PAGES

1596-1603

Identifiers

URI

http://scigraph.springernature.com/pub.10.1245/s10434-006-9047-3

DOI

http://dx.doi.org/10.1245/s10434-006-9047-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1035624784

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16957966


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Feasibility Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastrointestinal Stromal Tumors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Imatinib Mesylate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medical Records", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Necrosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peritoneal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piperazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Preoperative Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein-Tyrosine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrimidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Surgery, Institut Gustave Roussy, 94805, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bonvalot", 
        "givenName": "S.", 
        "id": "sg:person.01114352422.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114352422.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Surgery, Institut Gustave Roussy, 94805, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eldweny", 
        "givenName": "H.", 
        "id": "sg:person.01261756132.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261756132.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Radiotherapy, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "P\u00e9choux", 
        "givenName": "C. Le", 
        "id": "sg:person.01104541475.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104541475.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Radiology, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vanel", 
        "givenName": "D.", 
        "id": "sg:person.01036545346.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036545346.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Pathology, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Terrier", 
        "givenName": "P.", 
        "id": "sg:person.01157213662.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157213662.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Surgery, Institut Gustave Roussy, 94805, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cavalcanti", 
        "givenName": "A.", 
        "id": "sg:person.01316771114.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316771114.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Medical Oncology, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Robert", 
        "givenName": "C.", 
        "id": "sg:person.011436723362.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011436723362.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Radiology, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lassau", 
        "givenName": "N.", 
        "id": "sg:person.0745512151.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745512151.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Medical Oncology, Institut Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cesne", 
        "givenName": "A. Le", 
        "id": "sg:person.0647047157.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647047157.16"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1097/00000658-200001000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002575802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-200001000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002575802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cad.0000132236.38297.a7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005289424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cad.0000132236.38297.a7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005289424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)80608-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007366528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)80608-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007366528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(04)17098-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012604875"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdi127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013401985"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00261-003-0021-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021193217", 
          "https://doi.org/10.1007/s00261-003-0021-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa020461", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022255922"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0093-7754(01)90099-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024450281"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/aso.2004.09.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026114831", 
          "https://doi.org/10.1245/aso.2004.09.011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/aso.2004.09.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026114831", 
          "https://doi.org/10.1245/aso.2004.09.011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200104053441404", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026751453"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004280000338", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027401391", 
          "https://doi.org/10.1007/s004280000338"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000074470", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033746965"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejrad.2005.01.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034339089"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejso.2004.06.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035818796"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)00836-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039677991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)00836-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039677991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/hupa.2002.123545", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039925107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.11-1-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045697619"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjsurg.2003.08.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047135793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800051093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049559447", 
          "https://doi.org/10.1007/s002800051093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0039-6060(03)00314-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053453048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/sonc.2001.29181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057078474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-12", 
    "datePublishedReg": "2006-12-01", 
    "description": "BACKGROUND: The role for surgery in patients with \"unresectable\" gastrointestinal stromal tumors (GIST) treated with imatinib is still not defined. The objective of this retrospective study was to evaluate the feasibility and benefit of this secondary surgery.\nMETHODS: Progression-free survival (PFS) in a group of patients who underwent secondary surgery was compared to that of patients treated exclusively with imatinib.\nRESULTS: Of 180 patients with unresectable GIST treated with Imatinib, 22 (12%) underwent secondary surgery, following which one patient achieved a complete radiological response, 19 achieved a partial response (PR), in one patient the disease was stable, and in one patient there was reactivation of local occlusive disease after an initial PR. No patient with overall progression was to undergo surgery. At the beginning of imatinib therapy, five patients with metastases underwent emergency surgery [hemorrhage (n = 3) due to rupture of large necrotic masses], which ultimately resulted in three of the five patients dying postoperatively. A macroscopically complete resection was achieved in all primary tumors (5/5) and in ten of the 17 metastases. Pathological analysis revealed two complete response (CR) and 17 PR, and no treatment effect was evidenced in three patients. Two-year overall survival after surgery was 62%. The median PFS calculated from the initiation of imatinib therapy was 18.7 months for all operated patients and 23.4 months after planned surgery.\nCONCLUSION: Primary tumors that become amenable to surgery with prior imatinib therapy, evolving necrosis and localized progression (to avoid life-threatening complications) could benefit from this secondary surgery. For the majority of other residual lesions, the potential benefit of secondary surgery should be evaluated in randomized studies in the future since PFS is similar to that reported among non-operated patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1245/s10434-006-9047-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "name": "Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era", 
    "pagination": "1596-1603", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a9b447ab23dd04c832a8c7ee24cc14c6e538ebd29197dc8e22feb816b0e328d5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16957966"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9420840"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1245/s10434-006-9047-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1035624784"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1245/s10434-006-9047-3", 
      "https://app.dimensions.ai/details/publication/pub.1035624784"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000500.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1245/s10434-006-9047-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-006-9047-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-006-9047-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-006-9047-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-006-9047-3'


 

This table displays all metadata directly associated to this object as RDF triples.

291 TRIPLES      21 PREDICATES      74 URIs      44 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1245/s10434-006-9047-3 schema:about N0a0814c8d2aa499690c877c5ef4b08a5
2 N0d09568463eb4649baf7aedfba03d3a7
3 N0e7fa560f087409dabdeec17207f3bb5
4 N2ae37ccd78544e7faa55a4884db3fbc1
5 N2c6f60f1c6774bc5a8b4367b53e82b99
6 N310ce8f612274392a3e5275ada5a3d8a
7 N386485b5939f443699a818d19c320678
8 N591d778180e54b20b106cfac39e7a20a
9 N656e1fe21de745b89d50f18500002ec6
10 N672ea2313a6c4becb12735bf71194a75
11 N6dd7c495113c4f9191e92b69f33f9035
12 N8053322ebf124b11b8f57b44239941d5
13 N8406c8649b7f4d73be8663bc3c3f1bc0
14 N8b651f29494147fbaaec7dc0b8ac44ba
15 Na603d0faf8744e7c88882331dfe6325c
16 Naac204fa2b1d46cd818b0222b1222cdb
17 Nb4f318b2266446dab0c7ed909e998a00
18 Nc0fb2566cdef44b49427479928084fd4
19 Nd2cb4e948bb24279982a83c55e5f25af
20 Neb10d32394a2443598cd42e1f68c31dd
21 Ned9e56690b2d4529b14c6643c6121285
22 Nf3569df9747a4c7da6da1c0399d733cc
23 Nf691587c40bb4642861d19ef83048246
24 anzsrc-for:11
25 anzsrc-for:1103
26 schema:author N1b34341ec0ed47e9848f11706bd7a8c7
27 schema:citation sg:pub.10.1007/s00261-003-0021-2
28 sg:pub.10.1007/s002800051093
29 sg:pub.10.1007/s004280000338
30 sg:pub.10.1245/aso.2004.09.011
31 https://doi.org/10.1016/j.amjsurg.2003.08.023
32 https://doi.org/10.1016/j.ejrad.2005.01.012
33 https://doi.org/10.1016/j.ejso.2004.06.016
34 https://doi.org/10.1016/s0039-6060(03)00314-3
35 https://doi.org/10.1016/s0093-7754(01)90099-5
36 https://doi.org/10.1016/s0140-6736(04)17098-0
37 https://doi.org/10.1016/s0959-8049(02)00836-5
38 https://doi.org/10.1016/s0959-8049(02)80608-6
39 https://doi.org/10.1053/hupa.2002.123545
40 https://doi.org/10.1053/sonc.2001.29181
41 https://doi.org/10.1056/nejm200104053441404
42 https://doi.org/10.1056/nejmoa020461
43 https://doi.org/10.1080/01621459.1958.10501452
44 https://doi.org/10.1093/annonc/mdi127
45 https://doi.org/10.1097/00000658-200001000-00008
46 https://doi.org/10.1097/01.cad.0000132236.38297.a7
47 https://doi.org/10.1159/000074470
48 https://doi.org/10.1634/theoncologist.11-1-9
49 schema:datePublished 2006-12
50 schema:datePublishedReg 2006-12-01
51 schema:description BACKGROUND: The role for surgery in patients with "unresectable" gastrointestinal stromal tumors (GIST) treated with imatinib is still not defined. The objective of this retrospective study was to evaluate the feasibility and benefit of this secondary surgery. METHODS: Progression-free survival (PFS) in a group of patients who underwent secondary surgery was compared to that of patients treated exclusively with imatinib. RESULTS: Of 180 patients with unresectable GIST treated with Imatinib, 22 (12%) underwent secondary surgery, following which one patient achieved a complete radiological response, 19 achieved a partial response (PR), in one patient the disease was stable, and in one patient there was reactivation of local occlusive disease after an initial PR. No patient with overall progression was to undergo surgery. At the beginning of imatinib therapy, five patients with metastases underwent emergency surgery [hemorrhage (n = 3) due to rupture of large necrotic masses], which ultimately resulted in three of the five patients dying postoperatively. A macroscopically complete resection was achieved in all primary tumors (5/5) and in ten of the 17 metastases. Pathological analysis revealed two complete response (CR) and 17 PR, and no treatment effect was evidenced in three patients. Two-year overall survival after surgery was 62%. The median PFS calculated from the initiation of imatinib therapy was 18.7 months for all operated patients and 23.4 months after planned surgery. CONCLUSION: Primary tumors that become amenable to surgery with prior imatinib therapy, evolving necrosis and localized progression (to avoid life-threatening complications) could benefit from this secondary surgery. For the majority of other residual lesions, the potential benefit of secondary surgery should be evaluated in randomized studies in the future since PFS is similar to that reported among non-operated patients.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree false
55 schema:isPartOf N1786981ef8324b75a7ae8ef1dc64fbc8
56 Nb0cf4bce96824b76bd87501f84f9faf8
57 sg:journal.1105545
58 schema:name Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era
59 schema:pagination 1596-1603
60 schema:productId N08a3afac1ec64c8fa5f8452c43006265
61 N7431ecdce9214f9997ac2ec37c7fc1d1
62 Na21c90e2b86d498894cec026ff5946bb
63 Ncbc5016ce8e04700aff7b98098797ee2
64 Ne116e23cc97b48b7939496fee51f8dc7
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035624784
66 https://doi.org/10.1245/s10434-006-9047-3
67 schema:sdDatePublished 2019-04-10T19:06
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher N400c4827235c457ba38913aeb23206c4
70 schema:url http://link.springer.com/10.1245/s10434-006-9047-3
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N08a3afac1ec64c8fa5f8452c43006265 schema:name doi
75 schema:value 10.1245/s10434-006-9047-3
76 rdf:type schema:PropertyValue
77 N0a0814c8d2aa499690c877c5ef4b08a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Retrospective Studies
79 rdf:type schema:DefinedTerm
80 N0d09568463eb4649baf7aedfba03d3a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Imatinib Mesylate
82 rdf:type schema:DefinedTerm
83 N0e7fa560f087409dabdeec17207f3bb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Medical Records
85 rdf:type schema:DefinedTerm
86 N1786981ef8324b75a7ae8ef1dc64fbc8 schema:issueNumber 12
87 rdf:type schema:PublicationIssue
88 N1b34341ec0ed47e9848f11706bd7a8c7 rdf:first sg:person.01114352422.70
89 rdf:rest Nef4f65a4f5f24bae8f3b81256bbfef66
90 N1b4aff13cdaa499ab2fbf4ec5220c27d rdf:first sg:person.01157213662.74
91 rdf:rest N42c4f2e0d69b41fb877402dd1802a39e
92 N23d94f657329438483ba4404618ff5cb rdf:first sg:person.01104541475.09
93 rdf:rest N3bcaeb8817304226a04376cce15a53e1
94 N2ae37ccd78544e7faa55a4884db3fbc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Middle Aged
96 rdf:type schema:DefinedTerm
97 N2c6f60f1c6774bc5a8b4367b53e82b99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Piperazines
99 rdf:type schema:DefinedTerm
100 N310ce8f612274392a3e5275ada5a3d8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Peritoneal Neoplasms
102 rdf:type schema:DefinedTerm
103 N386485b5939f443699a818d19c320678 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Survival Rate
105 rdf:type schema:DefinedTerm
106 N3bcaeb8817304226a04376cce15a53e1 rdf:first sg:person.01036545346.36
107 rdf:rest N1b4aff13cdaa499ab2fbf4ec5220c27d
108 N3ef490b329e446ab91b6bd249d1d6c21 rdf:first sg:person.0745512151.35
109 rdf:rest Nf3c1686ecfce436280f85feab06fc431
110 N400c4827235c457ba38913aeb23206c4 schema:name Springer Nature - SN SciGraph project
111 rdf:type schema:Organization
112 N42c4f2e0d69b41fb877402dd1802a39e rdf:first sg:person.01316771114.04
113 rdf:rest Ne5d54e77b36746efaf074d9a09b9a74e
114 N591d778180e54b20b106cfac39e7a20a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Benzamides
116 rdf:type schema:DefinedTerm
117 N656e1fe21de745b89d50f18500002ec6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Male
119 rdf:type schema:DefinedTerm
120 N672ea2313a6c4becb12735bf71194a75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Disease-Free Survival
122 rdf:type schema:DefinedTerm
123 N6dd7c495113c4f9191e92b69f33f9035 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Humans
125 rdf:type schema:DefinedTerm
126 N7431ecdce9214f9997ac2ec37c7fc1d1 schema:name readcube_id
127 schema:value a9b447ab23dd04c832a8c7ee24cc14c6e538ebd29197dc8e22feb816b0e328d5
128 rdf:type schema:PropertyValue
129 N8053322ebf124b11b8f57b44239941d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Necrosis
131 rdf:type schema:DefinedTerm
132 N8406c8649b7f4d73be8663bc3c3f1bc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Antineoplastic Agents
134 rdf:type schema:DefinedTerm
135 N8b651f29494147fbaaec7dc0b8ac44ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Female
137 rdf:type schema:DefinedTerm
138 Na21c90e2b86d498894cec026ff5946bb schema:name nlm_unique_id
139 schema:value 9420840
140 rdf:type schema:PropertyValue
141 Na603d0faf8744e7c88882331dfe6325c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Aged
143 rdf:type schema:DefinedTerm
144 Naac204fa2b1d46cd818b0222b1222cdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Protein-Tyrosine Kinases
146 rdf:type schema:DefinedTerm
147 Nb0cf4bce96824b76bd87501f84f9faf8 schema:volumeNumber 13
148 rdf:type schema:PublicationVolume
149 Nb4f318b2266446dab0c7ed909e998a00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Adult
151 rdf:type schema:DefinedTerm
152 Nc0fb2566cdef44b49427479928084fd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Adolescent
154 rdf:type schema:DefinedTerm
155 Ncbc5016ce8e04700aff7b98098797ee2 schema:name dimensions_id
156 schema:value pub.1035624784
157 rdf:type schema:PropertyValue
158 Nd2cb4e948bb24279982a83c55e5f25af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Pyrimidines
160 rdf:type schema:DefinedTerm
161 Ne116e23cc97b48b7939496fee51f8dc7 schema:name pubmed_id
162 schema:value 16957966
163 rdf:type schema:PropertyValue
164 Ne5d54e77b36746efaf074d9a09b9a74e rdf:first sg:person.011436723362.08
165 rdf:rest N3ef490b329e446ab91b6bd249d1d6c21
166 Neb10d32394a2443598cd42e1f68c31dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Liver Neoplasms
168 rdf:type schema:DefinedTerm
169 Ned9e56690b2d4529b14c6643c6121285 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Feasibility Studies
171 rdf:type schema:DefinedTerm
172 Nef4f65a4f5f24bae8f3b81256bbfef66 rdf:first sg:person.01261756132.64
173 rdf:rest N23d94f657329438483ba4404618ff5cb
174 Nf3569df9747a4c7da6da1c0399d733cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Gastrointestinal Stromal Tumors
176 rdf:type schema:DefinedTerm
177 Nf3c1686ecfce436280f85feab06fc431 rdf:first sg:person.0647047157.16
178 rdf:rest rdf:nil
179 Nf691587c40bb4642861d19ef83048246 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Preoperative Care
181 rdf:type schema:DefinedTerm
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
186 schema:name Clinical Sciences
187 rdf:type schema:DefinedTerm
188 sg:journal.1105545 schema:issn 1068-9265
189 1534-4681
190 schema:name Annals of Surgical Oncology
191 rdf:type schema:Periodical
192 sg:person.01036545346.36 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
193 schema:familyName Vanel
194 schema:givenName D.
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036545346.36
196 rdf:type schema:Person
197 sg:person.01104541475.09 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
198 schema:familyName Péchoux
199 schema:givenName C. Le
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104541475.09
201 rdf:type schema:Person
202 sg:person.01114352422.70 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
203 schema:familyName Bonvalot
204 schema:givenName S.
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114352422.70
206 rdf:type schema:Person
207 sg:person.011436723362.08 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
208 schema:familyName Robert
209 schema:givenName C.
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011436723362.08
211 rdf:type schema:Person
212 sg:person.01157213662.74 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
213 schema:familyName Terrier
214 schema:givenName P.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157213662.74
216 rdf:type schema:Person
217 sg:person.01261756132.64 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
218 schema:familyName Eldweny
219 schema:givenName H.
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261756132.64
221 rdf:type schema:Person
222 sg:person.01316771114.04 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
223 schema:familyName Cavalcanti
224 schema:givenName A.
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316771114.04
226 rdf:type schema:Person
227 sg:person.0647047157.16 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
228 schema:familyName Cesne
229 schema:givenName A. Le
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647047157.16
231 rdf:type schema:Person
232 sg:person.0745512151.35 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
233 schema:familyName Lassau
234 schema:givenName N.
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745512151.35
236 rdf:type schema:Person
237 sg:pub.10.1007/s00261-003-0021-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021193217
238 https://doi.org/10.1007/s00261-003-0021-2
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/s002800051093 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049559447
241 https://doi.org/10.1007/s002800051093
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/s004280000338 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027401391
244 https://doi.org/10.1007/s004280000338
245 rdf:type schema:CreativeWork
246 sg:pub.10.1245/aso.2004.09.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026114831
247 https://doi.org/10.1245/aso.2004.09.011
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1016/j.amjsurg.2003.08.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047135793
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1016/j.ejrad.2005.01.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034339089
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1016/j.ejso.2004.06.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035818796
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1016/s0039-6060(03)00314-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053453048
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1016/s0093-7754(01)90099-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024450281
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1016/s0140-6736(04)17098-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012604875
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1016/s0959-8049(02)00836-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039677991
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1016/s0959-8049(02)80608-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007366528
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1053/hupa.2002.123545 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039925107
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1053/sonc.2001.29181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057078474
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1056/nejm200104053441404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026751453
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1056/nejmoa020461 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022255922
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1093/annonc/mdi127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013401985
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1097/00000658-200001000-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002575802
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1097/01.cad.0000132236.38297.a7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005289424
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1159/000074470 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033746965
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1634/theoncologist.11-1-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045697619
284 rdf:type schema:CreativeWork
285 https://www.grid.ac/institutes/grid.14925.3b schema:alternateName Institut Gustave Roussy
286 schema:name Department of Surgery, Institut Gustave Roussy, 94805, Villejuif, France
287 Medical Oncology, Institut Gustave Roussy, Villejuif, France
288 Pathology, Institut Gustave Roussy, Villejuif, France
289 Radiology, Institut Gustave Roussy, Villejuif, France
290 Radiotherapy, Institut Gustave Roussy, Villejuif, France
291 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...